Cork father heartbroken with HSE decision not to fund 'game-changer' drug
Cork

Cork father heartbroken with HSE decision not to fund 'game-changer' drug

Echo Live logoEcho Live

Around 200 people in Ireland are living with the rare neurological disease, but Skyclarys is priced at approximately €280,000 per patient per year.